2026 Conferences
29thEuropean GERPAC Conference
September 30, 2026 and October 1 & 2, 2026 - Hyères - France
In this space, you will find all the congress communications including conferences, round table, short oral communications and poster presentations.
Opening of the conference
Concurrent workshops
Access to replay of these recorded presentations
Coming soon
Workshop 1: Workplace quality of life
Prof. Pascal Bonnabry (HUG - Switzerland)Dr Audrey Flornoy (HUG - Switzerland) Workshop2: Managing Extractables and Leachables in Hospital Pharmacy Practices: Challenges and Insights Dr Philip Chennel (Clermont-Ferrand - France)
Dr William BELLO (Lausanne - Switzerland) Workshop 3: Microbiological environmental monitoring Dr Frédéric Marçon (CHU Amiens-Picardie - France)
Dr Thomas Storme (CH Bretagne Atlantique, Vannes - France) Workshop 4:Online reporting of hospital preparations (Prhosper tool): overview and discussion Brigitte Rogeau (ANSM) - Alain Richard (ANSM) - Dr ML Brandely-Piat (Cochin, AP-HP, France) Workshop 5: Developing a Business Continuity Plan Dr Laurent Carrez / Dr Greg Baldini (Lausanne - Switzerland)
Biopharmacy
Access to replay of these recorded presentations
Coming soon
Moderator
Prof. Frédéric Lagarce (CHU Angers - France)
From API sourcing to systemic exposure: a biopharmaceutical perspective
Dr Frédéric Marçon (Amiens-Picardie University Hospital / University of Picardie Jules Verne, Amiens - France)
Practical biopharmaceutics
Prof. Hannah Batchelor (University of Strathclyde, Glasgow - Scotland)
Quality of work life
Moderator
Prof. Sylvie Crauste-Manciet (CHU Angers - France)
Access to replay of these recorded presentations
Coming soon
Overview of risks in pharmaceutical technology
Prof. Pascal Bonnabry (HUG - Switzerland)
Exposure of healthcare professionals to cytotoxic drugs in Europe
Nadège JACOBY (INRS, France)
Prevention and Solutions: An Ergonomic and Systems-Based Approach to Occupational Risks
Jérémy Gautreau (GHBS Lorient - France)
News from European working groups
Access to replay of these recorded presentations
Coming soon
GERPAC Special Interest Groups 3D Printing
Dr Anna Lechanteur (Liège - Belgium)
GERPAC Special Interest Groups Automation
Prof I. Krämer (Mainz - DE)
Débats UK
Access to replay of these recorded presentations
Coming soon
Debates
Prof. Frédéric Lagarce (Angers, FR)
Should needles be eliminated?
For: Dr Lucie Bouchoud (HUG - Switzerland)Against: Dr Thomas Storme (CH Bretagne Atlantique, Vannes - France)
Is a final check analytical of chemotherapy preparations necessary?
For: Dr Camille Merrienne (Lyon - France)Against: Dr Laurent Carrez (Lausanne - Switzerland)
Pharmaceutical Technology Master award
Moderators
Prof. Sylvie Crauste-Manciet - Prof. Frédéric Lagarce, (CHU Angers - France)
Restoring MAPK signalling in the skin: pharmaceutical development and non-clinical evaluation of a topical BRAF inhibitor gel for EGFR inhibitor induced acneiform rash
M. Claus a, S. Ramos a,b, FX. Legrand b, P. Lavaud c, L. Zullo c, M. Girardon a,d, S. Durand a,d, I. Alonso-Garcia e, L. Friboulet e, B. Besse c,e, B. Do a,d; M. Annereau a,d,f
a. Department of Clinical Pharmacy, Gustave Roussy, Villejuif, France
b. Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.
c. Department of Medical Oncology, Gustave Roussy, Villejuif, France
d. UMR 1015 / IHU PRISM, Villejuif, France
e. INSERM U 981Gustave Roussy
f. UMR1360, - Oncogenesis,resistance and therapeutic targets of pediatric cancers, Villejuif France
Pharmaceutical development and stability-indicating high-performance liquid chromatography characterization of an insulin ophthalmic formulation for the treatment of persistent corneal epithelial defects
A. Mariot, M. Barrieu, Y. Bouattour, P. Chennell
Université Clermont-Ferrand Auvergne, CHU Clermont-Ferrand, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France
Restoring MAPK signalling in the skin: pharmaceutical development and non-clinical evaluation of a topical BRAF inhibitor gel for EGFR inhibitor induced acneiform rash
M. Claus a, S. Ramos a,b, FX. Legrand b, P. Lavaud c, L. Zullo c, M. Girardon a,d, S. Durand a,d, I. Alonso-Garcia e, L. Friboulet e, B. Besse c,e, B. Do a,d; M. Annereau a,d,f
a. Department of Clinical Pharmacy, Gustave Roussy, Villejuif, Franceb. Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.
c. Department of Medical Oncology, Gustave Roussy, Villejuif, France
d. UMR 1015 / IHU PRISM, Villejuif, France
e. INSERM U 981Gustave Roussy
f. UMR1360, - Oncogenesis,resistance and therapeutic targets of pediatric cancers, Villejuif France
Pharmaceutical development and stability-indicating high-performance liquid chromatography characterization of an insulin ophthalmic formulation for the treatment of persistent corneal epithelial defects
A. Mariot, M. Barrieu, Y. Bouattour, P. Chennell Université Clermont-Ferrand Auvergne, CHU Clermont-Ferrand, CNRS, Sigma Clermont, ICCF, F-63000 Clermont-Ferrand, France
GERPAC award 2026 for the best oral communication
GERPAC award 2026 for the best oral E-Poster: Analytical and microbiological techniques
GERPAC award 2026 for the best oral E-Poster session: Stability studies / Formulation and Quality Control
GERPAC award 2026 for the best oral E-Poster session: Production and automation processes (1)
GERPAC award 2026 for the best oral E-Poster session: Production and automation processes (2)
GERPAC award 2026 for the best oral E-Poster session : Quality Assurance, Risk Analysis and CSR
Short oral communications
Selection of short oral and E-Posters communications
Moderators
Prof I. Krämer (Mainz, Germany)Dr P Chennell (Clermont-Ferrand, France)
Dr I. Roland (Liège, Belgium)
Simulation of a backup circuit for pediatric parenteral nutrition, from prescription to administration
H. Outaararate, H. Roussel, V. ServantSterile Production Unit, Pellegrin Hospital, Bordeaux University Hospital, France
Application of an Industrial Aseptic Process Simulation Methodology to the Preparation of Chemotherapy Drugs in Hospitals
L. Hamlaoui-Chareuf 1, J. Poizot 1, C. Lestrez 1, A. Lecoutre 1, J. Courtin 1, M. Vasseur 1,2, P. Odou 1,21. Lille University Hospital, Institute of Pharmacy, F-59000 Lille, France
2. University of Lille, ULR 7365 – GRITA – Research Group on Injectable Formulations and Associated Technologies, F-59000 Lille, France
HabiliUp®: a digital tool for the competency reassessment of hospital pharmacy technicians
M. Bettayeb, K. Jossot, M. Brun, A. Hammadi, R. Desmaris, C. CrosInstitut Curie Paris, 26 Rue d’Ulm, 75005 Paris
Impact of repackaging on the physical stability of tablets in hospital pharmacy practice
A.Gagba, I.Belaïd, V.BlochHospital Pharmacy – Pharmaceutical Technology Unit, Hôpital Lariboisière - Fernand Widal, AP-HP, Paris, France
Institutional hospital-based production of the therapeutic bacteriophages
C. Mérienne 1, C. Marchand 1,, B. Lapras 1, M. Medina 3,4, C. Paillet1, F. Laurent 3,4, F. Pirot 1,21. Hospices Civils de Lyon, GHC, Pharmacy department and FRIPHARM®, 69007 Lyon
2. Claude Bernard Lyon 1 University, CNRS/UMR 5305: LBTI, 69007 Lyon
3. Claude Bernard Lyon 1 University, INSERM U1111- CNRS UMR5308 CIRI (Centre International de Recherche en Infectiologie), 69007 Lyon
4. Hospices Civils de Lyon, GHN, Institute for Infectious Agents, 69004 Lyon
Implementation of a Digital Visual Inspection Tool in a Centralized Antineoplasic Drug preparation Unit
Z. Caby, D. Dautel, A. Danckaert, A. Houbert, L. Real Centre Hospitalier d’Arras, Pharmacie, France
Development of a sterile gospital-compounded crystalloid cardioplegic solution to ensure continuity care
J.B. Paradis1, V. Lequeux 1,2, M. Azzaz 1,2, A. Bensahkoun 1,2, C. Merienne 1,2, C. Marchand 1,2, F. Pirot 1,21. Drug Compounding and Quality Control Unit, FRIPHARM Platform, Department of Hospital Pharmacy, Edouard Herriot Hospital Group, Hospices Civils de Lyon, Lyon, France.
2. Claude Bernard Lyon 1 University, Lyon Faculty of Pharmacy, Tissue Biology and Therapeutic Engineering Laboratory (LBTI), CNRS UMR 5305, Lyon, France
Assessment of the contamination risk in an automated system for the repackaging of oral liquid medications (ADP-20L)
Y. Habib1, M. Bouchfaa1,2, L. Négrier1,2, M. Masse1,2, S. Gilliot1,2, M. Vasseur1,2, C. Danel1,2, P. Odou1,21. Université de Lille, France
2. Centre Hospitalier Universitaire de Lille, France
Physicochemical stability of CPX-351 (Vyxeos®) 0.6 mg/mL infusion solutions in prefilled 5% glucose infusion bags
H. Linxweiler, J. Thiesen, I. KrämerDepartment of Pharmacy, University Medical Centre of Johannes Gutenberg-University, Langenbeckstraße 1, 55131 Mainz, Germany
Performance qualification of the Kiro Isolator® robotic system through decontamination challenge testing
J. Pereira, M. Garos, A. Peronnaud, A. Jouvance-Le Bail, MA Lester.Cytotoxic Reconstitution Unit, Rennes University Hospital, France.
Evaluation of a new subcutaneous daratumumab administration device
W. Johnson, C. Laruelle, A. Abomo Ngoo, J. Maslo, J. Georger, MA. Marchal, J. Chappe, M. Rigal, A. Jacolot, S. SinghPharmacie à Usage Intérieur, APHP Hôpitaux Universitaires Paris-Seine-Saint-Denis, Site Avicenne, 93000 Bobigny, France
Development of a New Dosage Form of Pentoxifylline Using 3D Printing
K. Fouda, S. Ramos, S. Guevara, M. Annereau, B. DoDepartment of Clinical Pharmacy – Gustave Roussy, France
Can generative AI support risk mapping in hospital radiopharmacy? Comparison of six generative models
A. Crou, T. Tang, D. Kanan, P. Junior Onzo, S. Blondeel-Gomes, F. El KouariPharmacie, Groupe Hospitalier Grand Paris Nord-Est, GHI Le Raincy Montfermeil, France
Impact of Augmented Reality-Assisted In-Process Quality Control (FlexOprep®) on the Safety and Traceability of Chemotherapy Preparations
L. Istace 1, O. Leynen 1, M. Denoël 1, I. Roland 2 1. Pharmacy Department CSL Arlon Vivalia, Belgium
2. Pharmacy Department CHU Liège, Belgium
Managing microbiological risk: defining alert thresholds from historical data of a production environment
M. Bourguilleau, F. MarçonCentre Hospitalier Universitaire Amiens Picardie, France
Evaluation of vial crimping integrity using vacuum decay testing and internal pressure monitoring
A. Zainoutdinov1, V. Lequeux1,2, M. Grimopont1, A. Choquet-Botella1, C. Merienne1, C. Marchand1, F. Pirot1,21 Pharmacy Department, Hospices Civils de Lyon, Edouard Herriot Hospital, FRIPHARM Platform, 69437, Lyon, France.
2 Laboratory of Tissue Biology and Therapeutic Engineering (LBTI), CNRS UMR 5305, 69007, Lyon, France.
Validation of the Cleaning Process for a Semi-Automatic Capsule Filler
L. Hamlaoui-Chareuf 1, L. Négrier 1,2, M. Bouchfaa 1,2, L. Pacqueu 1, S. Gilliot 1,2, C. Berneron 1, M. Vasseur 1,2, P. Odou 1,2, C. Danel 1,21. Lille University Hospital, Institute of Pharmacy, F-59000 Lille, France
2. University of Lille, ULR 7365 – GRITA – Research Group on Injectable Formulations and Associated Technologies, F-59000 Lille, France
Training for the unexpected: an immersive simulation serious game for chemical incident management
O. Bardou, D. Giraud, E. Pinet, N. Valin, E. Caudron, L. LeHôpital Européen Georges Pompidou, Paris, France
While maintaining the same level of quality and safety, is it possible to optimize the energy efficiency of a ZAC ?
A. Patry, C. Vetillard, E. Le Bourrhis, M. Dupuy, I. Girault, L. Jemour, H. PerrierCentre hospitalier du Mans, 194 Av. Rubillard, 72037 Le Mans
Performance Evaluation and Operational Limits of Five Automated Sterile Compounding Systems
G. Sayet, O. Techec, A. Rasiah, M-G. Philipot, S. Bansart, M-C. DespiauHôpital National de la vision - Paris 15-20, 28 rue de Charenton, Paris, France
Glycation and oxidation: key determinants of the physicochemical behaviour of trastuzumab deruxtecan (Enhertu®) in a glucose infusion solution
C. Juul1, Y. Mayssa Bendiab1, E. Hindès1, V. Cochard2, Salma Fourati3, D. Combeau1, G. Chevreux, M. Antignac1, H. Sadou Yayé11. Service de Pharmacie à usage intérieur, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France
2. Université Paris Cité, CNRS, Institut Jacques Monod, Paris, France
3. Service de Biochimie endocrinienne et oncologique, Hôpital Universitaire Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France
Validation of a Rapid Microbiological Method for Sterility Testing of Atropine Eye Drops
M. Dupont, L. Proust, J. Chan Chao Yun, A. Khan, A. VenetPharmaceutical Technology Department, Bordeaux University Hospital, France
Stability Assessment of hospital-produced anti-staphylococcal phage therapeutic medicinal Products
C. Mérienne 1,4, B. Lapras 1,3,4, C. Marchand 1,4, C. Kolenda 2,4, A. Von-Kanel 1,4, M. Medina 2,4, F. Laurant 2,4, F. Pirot 1,3,41. FRIPHARM®, Pharmacie à usage intérieur, Groupement Hospitalier Centre - Hospices Civils de Lyon (HCL), France
2. Laboratoire de bactériologie, Centre national de référence des staphylocoques – HCL, France
3. UMR 5305: Laboratoire de Biologie Tissulaire et d’Ingénierie Thérapeutique, Institut de Biologie et Chimie des Protéines, CNRS/Université Claude Bernard Lyon 1, France
4. Consortium PHAGEinLYON-PHAG-ONE, France
E-Posters - Session A: Analytical and microbiological techniques
Development and validation of a stability-indicating analytical method for evaluating the physico- chemical stability of amoxicillin/clavulanic acid capsules for oral provocation tests
L. Négrier 1,2, M. Dhote 1, L. Hamlaoui-Chareuf 1, L. Pacqueu 1, M. Bouchfaa 1, P. Odou 1,2, C. Danel 1,2
1. CHU de Lille, Institut de Pharmacie, 59000 Lille, France
2. Univ. Lille, ULR 7365 - GRITA – Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France Development, Analytical Validation and Stability Study of Low-Dose Atropine Eye Drops Prepared from Pharmaceutical-Grade Atropine Sulfate Powder G. Sayet, S. Bansart, M-G. Philipot, M-C. Despiau
Hôpital National de la vision - Paris 15-20, 28 rue de Charenton, Paris, France
Comparison of analytical techniques for the quantification of bacterial endotoxins in injectable preparations using the additive color method O. Allard 1, M. Barrieu 2, J. Claves 1, Y. Bouattour 1, P. Chennell 2
1. CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2. Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
Neonatal epilepsy: Development and validation of an HPLC-UV method for carbamazepine dosage S. Zaoui, M. Dayre, J. Roupret-Serzec, F. Rioblanc
APHP, Hôpital Robert Debré, PUI, Paris, France
Carryover contamination in routine HPLC analytical control within a sterile injectable compounding unit: impact on analytical reliability and implementation of a corrective cleaning procedure F. Kérourédan 1, J.M. Bernadou 1, S. Dubois 1, A. Berroneau 1, G. Bouguéon 1,2
1. Pharmaceutical Technology Department, Bordeaux University Hospital, Pessac, France
2. ARNA laboratory, ChemBioPharm, INSERM U1212, UMR 5320 CNRS, University of Bordeaux, France
Photoprotection versus patient identification safety : evaluation of overwraps for anticancer drug bags C. Desrichard 1, R. Lanery 2 , G. Boccadifuoco 2, N. Le Guyader 1, E. Jaccoulet 2, Z. Ribier 1
1. Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France
2. Agence Générale des Equipements et Produits de Santé, Paris, France
Validation of a stability-indicating HPLC-UV method: a prerequisite for conducting a stability study of an oral solution of isavuconazonium A. Rusch 1, M. Petit 1,2, A. Meddeb 1, A. Dory 1,3, G. Ubeaud-Sequier 1,2, B. Gourieux 1,3
1. Service Pharmacie-Stérilisation des Hôpitaux Universitaires de Strasbourg, France
2. UMR 1260 Nanomédecines Régénératives, INSERM et Université de Strasbourg, France
3. UR 7296 Laboratoire de pharmacologie et toxicologie neurocardiovasculaire, Université de Strasbourg, France
Centralization of vitamin-lipid blend production: validation of the alternative Bactec® method for sterility testing A. Ressel, B. Mathat, E. Olivier, C. Baguet, N. Cormier
Centre Hospitalier Universitaire de Nantes, site Hôtel-Dieu, Nantes, France
Centralization of vitamin-lipid blend production: validation of membrane filtration for sterility testing A. Ressel, B. Mathat, E. Olivier, C. Baguet, N. Cormier
Centre Hospitalier Universitaire de Nantes, site Hôtel-Dieu, Nantes, France
1. CHU de Lille, Institut de Pharmacie, 59000 Lille, France
2. Univ. Lille, ULR 7365 - GRITA – Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France Development, Analytical Validation and Stability Study of Low-Dose Atropine Eye Drops Prepared from Pharmaceutical-Grade Atropine Sulfate Powder G. Sayet, S. Bansart, M-G. Philipot, M-C. Despiau
Hôpital National de la vision - Paris 15-20, 28 rue de Charenton, Paris, France
Comparison of analytical techniques for the quantification of bacterial endotoxins in injectable preparations using the additive color method O. Allard 1, M. Barrieu 2, J. Claves 1, Y. Bouattour 1, P. Chennell 2
1. CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2. Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
Neonatal epilepsy: Development and validation of an HPLC-UV method for carbamazepine dosage S. Zaoui, M. Dayre, J. Roupret-Serzec, F. Rioblanc
APHP, Hôpital Robert Debré, PUI, Paris, France
Carryover contamination in routine HPLC analytical control within a sterile injectable compounding unit: impact on analytical reliability and implementation of a corrective cleaning procedure F. Kérourédan 1, J.M. Bernadou 1, S. Dubois 1, A. Berroneau 1, G. Bouguéon 1,2
1. Pharmaceutical Technology Department, Bordeaux University Hospital, Pessac, France
2. ARNA laboratory, ChemBioPharm, INSERM U1212, UMR 5320 CNRS, University of Bordeaux, France
Photoprotection versus patient identification safety : evaluation of overwraps for anticancer drug bags C. Desrichard 1, R. Lanery 2 , G. Boccadifuoco 2, N. Le Guyader 1, E. Jaccoulet 2, Z. Ribier 1
1. Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France
2. Agence Générale des Equipements et Produits de Santé, Paris, France
Validation of a stability-indicating HPLC-UV method: a prerequisite for conducting a stability study of an oral solution of isavuconazonium A. Rusch 1, M. Petit 1,2, A. Meddeb 1, A. Dory 1,3, G. Ubeaud-Sequier 1,2, B. Gourieux 1,3
1. Service Pharmacie-Stérilisation des Hôpitaux Universitaires de Strasbourg, France
2. UMR 1260 Nanomédecines Régénératives, INSERM et Université de Strasbourg, France
3. UR 7296 Laboratoire de pharmacologie et toxicologie neurocardiovasculaire, Université de Strasbourg, France
Centralization of vitamin-lipid blend production: validation of the alternative Bactec® method for sterility testing A. Ressel, B. Mathat, E. Olivier, C. Baguet, N. Cormier
Centre Hospitalier Universitaire de Nantes, site Hôtel-Dieu, Nantes, France
Centralization of vitamin-lipid blend production: validation of membrane filtration for sterility testing A. Ressel, B. Mathat, E. Olivier, C. Baguet, N. Cormier
Centre Hospitalier Universitaire de Nantes, site Hôtel-Dieu, Nantes, France
E-Posters - Session B: Stability studies / Formulation and Quality Control
Preclinical evaluation of the tolerance of an injectable bacteriophage suspension developed in an academic setting
C. Marchand 1, B. Lapras 1, M. Medina 2, M. Grimopont 1, C. Merienne 1, F. Laurent 2,3, F. Pirot 1,4
1. FRIPHARM Platform, Hospital Pharmacy Groupement Hospitalier Centre, Hospices Civils de Lyon, France
2. Institute of Infectious Agents, Groupement Hospitalier Nord, Hospices Civils de Lyon, France
3. Claude Bernard Lyon 1 University, INSERM U1111- CNRS UMR5308 CIRI (International Center for Infectiology Research), 69007 Lyon, France
4. Université Claude Bernard Lyon 1, Faculty of Pharmacy of Lyon, Tissue Biology and Therapeutic Engineering Laboratory (LBTI) UMR CNRS 5305, Lyon, France Stability study of a 5 mg/mL oral vinorelbine solution in Inorpha® M. Lac, N. Raymundo, P. Claraz, C. Guillemot
Institut Universitaire du cancer de Toulouse - Oncopole, Toulouse, France
Preparation and Quality Control of 3D printed Spironolactone Gel-Tablets for Paediatric Patients T. Vincze 1, M. Tubic-Grozdanis 1, I. Krämer 1, J. Al-Gousous 2, P. Langguth 2
1. Department of Pharmacy, University Medical Center of Johannes Gutenberg-University, Langenbeckstr. 1, 55131 Mainz, Germany
2. Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudingerweg 5, 55128 Mainz, Germany
Trend analysis of microbiological contamination within a pharmaceutical compounding unit : towards a risk-based revision of the environmental monitoring sampling plan P. Boute, D Goulley, P Gueneau, C. Pernot
Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France Topical 2% Ketamine - % Amitriptyline Gel: Which Poloxamer 407 Concentration Should Be Selected? D. Coppée, M. Renault-Mahieux, F. Mette, V. Archer, A. Thouvenin
APHP, Hôpital Henri-Mondor, Créteil, France
Microbiological stability and antimicrobial preservative effectiveness of a 5 mg/mL spironolactone oral suspension in Inorpha® S. Tironi-Aragon, Z. Robert, H. Garrigue, F. Bordet, S. Muhammad, M-L. Maestroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Physicochemical stability study of 10 µg/mL Clonidine hydrochloride oral suspension in Syrspend® SF PH4 for pediatric use M-L Rousseau, M-A Lester, P-N Boivin, A-L Leroy
Centre Hospitalier Universitaire de Rennes, France Better qualifying students in the control laboratory using the "Error Lab" D. Ghoul 1, S. El Farsi 1, M. Petit 1,2, A. Dory1,3, G. Ubeaud-Sequier 1,2, B. Gourieux 1,3
1 Service Pharmacie-Stérilisation des Hôpitaux Universitaires de Strasbourg, France
2 UMR 1260 Nanomédecines Régénératives, INSERM et Université de Strasbourg, France
UR 7296 Laboratoire de pharmacologie et toxicologie neurocardiovasculaire, Université de Strasbourg, France
Physicochemical stability of dexmedetomidine diluted in 5% glucose solution in polypropylene syringes L. Chonkel, V. Vieillard, A. Dowek, M. Paul
Pharmacy Department, Henri Mondor Hospital, Créteil, France
Evaluation of Gabapentin Stability in a Suspension Vehicle Free from Potentially Harmful Excipients D. Coache, B. Tanguay, H. Gentès, J-P. Gentès
Galenova, Saint-Hyacinthe, Quebec, Canada
1. FRIPHARM Platform, Hospital Pharmacy Groupement Hospitalier Centre, Hospices Civils de Lyon, France
2. Institute of Infectious Agents, Groupement Hospitalier Nord, Hospices Civils de Lyon, France
3. Claude Bernard Lyon 1 University, INSERM U1111- CNRS UMR5308 CIRI (International Center for Infectiology Research), 69007 Lyon, France
4. Université Claude Bernard Lyon 1, Faculty of Pharmacy of Lyon, Tissue Biology and Therapeutic Engineering Laboratory (LBTI) UMR CNRS 5305, Lyon, France Stability study of a 5 mg/mL oral vinorelbine solution in Inorpha® M. Lac, N. Raymundo, P. Claraz, C. Guillemot
Institut Universitaire du cancer de Toulouse - Oncopole, Toulouse, France
Preparation and Quality Control of 3D printed Spironolactone Gel-Tablets for Paediatric Patients T. Vincze 1, M. Tubic-Grozdanis 1, I. Krämer 1, J. Al-Gousous 2, P. Langguth 2
1. Department of Pharmacy, University Medical Center of Johannes Gutenberg-University, Langenbeckstr. 1, 55131 Mainz, Germany
2. Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudingerweg 5, 55128 Mainz, Germany
Trend analysis of microbiological contamination within a pharmaceutical compounding unit : towards a risk-based revision of the environmental monitoring sampling plan P. Boute, D Goulley, P Gueneau, C. Pernot
Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France Topical 2% Ketamine - % Amitriptyline Gel: Which Poloxamer 407 Concentration Should Be Selected? D. Coppée, M. Renault-Mahieux, F. Mette, V. Archer, A. Thouvenin
APHP, Hôpital Henri-Mondor, Créteil, France
Microbiological stability and antimicrobial preservative effectiveness of a 5 mg/mL spironolactone oral suspension in Inorpha® S. Tironi-Aragon, Z. Robert, H. Garrigue, F. Bordet, S. Muhammad, M-L. Maestroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Physicochemical stability study of 10 µg/mL Clonidine hydrochloride oral suspension in Syrspend® SF PH4 for pediatric use M-L Rousseau, M-A Lester, P-N Boivin, A-L Leroy
Centre Hospitalier Universitaire de Rennes, France Better qualifying students in the control laboratory using the "Error Lab" D. Ghoul 1, S. El Farsi 1, M. Petit 1,2, A. Dory1,3, G. Ubeaud-Sequier 1,2, B. Gourieux 1,3
1 Service Pharmacie-Stérilisation des Hôpitaux Universitaires de Strasbourg, France
2 UMR 1260 Nanomédecines Régénératives, INSERM et Université de Strasbourg, France
UR 7296 Laboratoire de pharmacologie et toxicologie neurocardiovasculaire, Université de Strasbourg, France
Physicochemical stability of dexmedetomidine diluted in 5% glucose solution in polypropylene syringes L. Chonkel, V. Vieillard, A. Dowek, M. Paul
Pharmacy Department, Henri Mondor Hospital, Créteil, France
Evaluation of Gabapentin Stability in a Suspension Vehicle Free from Potentially Harmful Excipients D. Coache, B. Tanguay, H. Gentès, J-P. Gentès
Galenova, Saint-Hyacinthe, Quebec, Canada
E-Posters - Session C: Production and automation processes
Artificial intelligence-based video monitoring of cytotoxic drug preparation in an ISO 9001-certified unit: a ten-year review of over 300,000 preparations
B. Castro, P. Hardy, L. Gallay, M. Laplace, B. Dalifard, B. Le Franc, C.H. Blancher
Centre Hospitalier de La Rochelle, La Rochelle, France
Hospital Radiopharmacy: What Are the Roles of Hospital Pharmacy Technicians ? S. Robert 1 , E. Florit 2, S. Zitte 3, S. Meyer 4, M.C. Bros4
1. Centre Hospitalier de Montluçon, Néris-les-Bains, France
2. Institut du Cancer de Montpellier, France
3. Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre, France
4. Centre Hospitalier du Forez, Montbrison, France
Preliminary Evaluation of the Mundus HD Automated Compounding System (Equashield) in terms of Productivity, Accuracy, and Microbiological and Chemical Contamination Control M. Vasseur¹˒² , L. Négrier¹˒² , A. Lecoutre¹ , J. Courtin¹ , M. Bouchfaa¹˒² , N. Simon¹˒² , C. Danel¹˒² , P. Odou¹˒²
1. University of Lille, CHU Lille, Faculty of Pharmacy, 59000 Lille, France.
2. University of Lille, CHU Lille, ULR 7365 – GRITA – Research Group on Injectable Drug Forms and Associated Technologies, 59000 Lille, France. When pharmaceutical expertise is challenged in the preparation of investigational medicinal products E. Allouis, A.Riazi, M. Renault-Mahieux, V. Archer, M.Carvalho
APHP, Hôpital Henri Mondor, Créteil, France
Implementation of a system to assist in the preparation of vitamin-lipid syringes: an ampoule opener E. William, Y. Ho
APHP, Hôpital Armand-Trousseau, Paris, France Preliminary study to detect potential hydrogen peroxide permeability in medical packaging devices used for Advanced Therapy Medicinal Products L. Deramoudt 1,2, M. Leroy 1, M. Pinturaud 1,2, C. Danel 1,2, L. Negrier 1,2, C. Berneron 1, B. Gouverneur 1, J. Courtin 1, A. Lecoutre 1, M. Vasseur 1,2, N. Simon 1,2, P. Odou 1,2
1. Centre Hospitalier Universitaire Lille, France
2. Université de Lille, ULR 7365, GRITA, Lille, France
Back to Paper Age: Fake cyberattack / Real production – Real-world exercise in the CRU (Cytotoxic Reconstitution Unit) and the Day Hospital MC. Bros, L. Leyenberger, M. Andanson Macchi, E. Sigward
Centre Hospitalier de Montluçon – Néris les Bains, France Manual, cobotic, or semi-automated: which preparation mode for our 5-FU infusors? P. Dronsart, A. Hamza, Z. Senoudi, A. Bendjama, T. Martin, P. Coliat
Institut Strauss, Strasbourg, France
Seven months experience with a robot for the compounding of sterile chemotherapy preparations: activity analysis, performance and limitations E. Kadushkina, A. Delépine, R. Desmaris, M. Friou
Institut Curie, Saint-Cloud, France
Centre Hospitalier de La Rochelle, La Rochelle, France
Hospital Radiopharmacy: What Are the Roles of Hospital Pharmacy Technicians ? S. Robert 1 , E. Florit 2, S. Zitte 3, S. Meyer 4, M.C. Bros4
1. Centre Hospitalier de Montluçon, Néris-les-Bains, France
2. Institut du Cancer de Montpellier, France
3. Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre, France
4. Centre Hospitalier du Forez, Montbrison, France
Preliminary Evaluation of the Mundus HD Automated Compounding System (Equashield) in terms of Productivity, Accuracy, and Microbiological and Chemical Contamination Control M. Vasseur¹˒² , L. Négrier¹˒² , A. Lecoutre¹ , J. Courtin¹ , M. Bouchfaa¹˒² , N. Simon¹˒² , C. Danel¹˒² , P. Odou¹˒²
1. University of Lille, CHU Lille, Faculty of Pharmacy, 59000 Lille, France.
2. University of Lille, CHU Lille, ULR 7365 – GRITA – Research Group on Injectable Drug Forms and Associated Technologies, 59000 Lille, France. When pharmaceutical expertise is challenged in the preparation of investigational medicinal products E. Allouis, A.Riazi, M. Renault-Mahieux, V. Archer, M.Carvalho
APHP, Hôpital Henri Mondor, Créteil, France
Implementation of a system to assist in the preparation of vitamin-lipid syringes: an ampoule opener E. William, Y. Ho
APHP, Hôpital Armand-Trousseau, Paris, France Preliminary study to detect potential hydrogen peroxide permeability in medical packaging devices used for Advanced Therapy Medicinal Products L. Deramoudt 1,2, M. Leroy 1, M. Pinturaud 1,2, C. Danel 1,2, L. Negrier 1,2, C. Berneron 1, B. Gouverneur 1, J. Courtin 1, A. Lecoutre 1, M. Vasseur 1,2, N. Simon 1,2, P. Odou 1,2
1. Centre Hospitalier Universitaire Lille, France
2. Université de Lille, ULR 7365, GRITA, Lille, France
Back to Paper Age: Fake cyberattack / Real production – Real-world exercise in the CRU (Cytotoxic Reconstitution Unit) and the Day Hospital MC. Bros, L. Leyenberger, M. Andanson Macchi, E. Sigward
Centre Hospitalier de Montluçon – Néris les Bains, France Manual, cobotic, or semi-automated: which preparation mode for our 5-FU infusors? P. Dronsart, A. Hamza, Z. Senoudi, A. Bendjama, T. Martin, P. Coliat
Institut Strauss, Strasbourg, France
Seven months experience with a robot for the compounding of sterile chemotherapy preparations: activity analysis, performance and limitations E. Kadushkina, A. Delépine, R. Desmaris, M. Friou
Institut Curie, Saint-Cloud, France
E-Posters - Session D: Production and automation processes
Impact of CAR-T cell preparation procedures on the hospital pharmacist workload: A three-year retrospective comparative study between axicabtagene ciloleucel and lisocabtagene maraleucel
M.Wang, M. Mahieux-Renault, A. Riazi, W. Saeed, V. Cobrion-Archer, M. Carvalho, M. Dupre
Henri-Mondor University Hospital AP-HP, Créteil, France
Tracking the source of contamination in an isolator: contribution of chemical indicators and swab sampling A. Framery, V. Vincourt, C. Vicino, A. Podvin
Douai Hospital Center, Douai, France
Automated compounding of 5-fluorouracil elastomeric infusion pump: Impact on the prevention and reduction of musculoskeletal disorders through an ergonomic study A. Rainotte-Santraine 1, E. Neglokpe 1, C. Fercocq 2, R. Linossier-Rocher 2, Z. Abbassi 2, JL. Pons 2, A. Bruneau 2
1 Conservatoire National des Arts et Métiers de Paris, Paris, France
2 Pharmacie – Unité Centralisée de Préparation des Cytotoxiques, CH Victor Dupouy, Argenteuil, France
Performance qualification of a dual-channel compounding system Medimix Vigo® & +One® A. Bruneau, C. Fercocq, Z. Abbassi, JL. Pons, R. Linossier-Rocher
Centre Hospitalier Victor Dupouy, Argenteuil, France
Implementation of a video-traceability system (Drugcam®) for the compounding of injectable investigational anticancer drugs: experience from a hospital compounding unit E. Kadushkina, S. Jegaden, A. Delépine, R. Desmaris, C. Giard, M. Friou
Institut Curie, Saint-Cloud, France
Comparison of Manufacturing Process Robustness: From a Manual to an Automated Method C.Vallez 1, C. Razeyre 1 , F. Maillard 1 , D. Stefanelli 2, V. Delannoy 1
1. University Hospital of Nîmes, France
2. MB Therapeutics, France
Reallocation of sterile injectable preparations: what is the microbiological risk ? V. Tsvetanova, S. Singh, M. Rigal, A. Jacolot, M. Apparuit
Hôpital Avicenne - Hôpitaux Universitaires Paris Seine-Saint-Denis, AP-HP, France
Comparative analysis of regulatory frameworks governing 3D printing of medicines: an international review and implications for France K. Fouda 1, M. Anneraux 1, M. Bouley 2
1 Gustave Roussy, Villejuif, France
2 Scientific Affairs Division – French National Agency for the Safety of Medicines and Health Products
Henri-Mondor University Hospital AP-HP, Créteil, France
Tracking the source of contamination in an isolator: contribution of chemical indicators and swab sampling A. Framery, V. Vincourt, C. Vicino, A. Podvin
Douai Hospital Center, Douai, France
Automated compounding of 5-fluorouracil elastomeric infusion pump: Impact on the prevention and reduction of musculoskeletal disorders through an ergonomic study A. Rainotte-Santraine 1, E. Neglokpe 1, C. Fercocq 2, R. Linossier-Rocher 2, Z. Abbassi 2, JL. Pons 2, A. Bruneau 2
1 Conservatoire National des Arts et Métiers de Paris, Paris, France
2 Pharmacie – Unité Centralisée de Préparation des Cytotoxiques, CH Victor Dupouy, Argenteuil, France
Performance qualification of a dual-channel compounding system Medimix Vigo® & +One® A. Bruneau, C. Fercocq, Z. Abbassi, JL. Pons, R. Linossier-Rocher
Centre Hospitalier Victor Dupouy, Argenteuil, France
Implementation of a video-traceability system (Drugcam®) for the compounding of injectable investigational anticancer drugs: experience from a hospital compounding unit E. Kadushkina, S. Jegaden, A. Delépine, R. Desmaris, C. Giard, M. Friou
Institut Curie, Saint-Cloud, France
Comparison of Manufacturing Process Robustness: From a Manual to an Automated Method C.Vallez 1, C. Razeyre 1 , F. Maillard 1 , D. Stefanelli 2, V. Delannoy 1
1. University Hospital of Nîmes, France
2. MB Therapeutics, France
Reallocation of sterile injectable preparations: what is the microbiological risk ? V. Tsvetanova, S. Singh, M. Rigal, A. Jacolot, M. Apparuit
Hôpital Avicenne - Hôpitaux Universitaires Paris Seine-Saint-Denis, AP-HP, France
Comparative analysis of regulatory frameworks governing 3D printing of medicines: an international review and implications for France K. Fouda 1, M. Anneraux 1, M. Bouley 2
1 Gustave Roussy, Villejuif, France
2 Scientific Affairs Division – French National Agency for the Safety of Medicines and Health Products
E-Posters - Session E: Quality Assurance, Risk Analysis and CSR
Cytotoxic waste disposal: handling environmental contamination using the FMECA method
G. Sanchez 1, I. Dufrêne1, R. Pechaud 1, M. Rannou 1, L. Duchange 2, B. Anglaret 2, A-F. Dumas 1, H. Hida 1
1. Pharmacy department, Centre Hospitalier de Valence, France
2. Occupational health department, Centre Hospitalier de Valence, France
Securing the Preparation Process for Sterile Injectable Anticancer Drugs in a Cytotoxic Safety Cabinet L. Fourcaud, S. Hermann, G. Hily, D. Sankhare, N. Jourdan, I. Madelaine, M. Brault
APHP, Hôpital Saint-Louis, Paris, France
Environmental monitoring of residual contamination of work surfaces by 14 antineoplastic drugs in 11 French chemotherapy reconstitution units between 2023 and 2025 M. Nehlil 1, C. Wadela 2, B. Atgé 3, C. Sciaux 3, A. Villa 4,5, M. Canal-Raffin 1,2
1 Pharmacology and toxicology Laboratory, Bordeaux University Hospital, France
2 Inserm U1219, EPICENE team, University of Bordeaux, France
3 AHI 33, Bordeaux, France
4 Occupational and Environmental Pathology Department, Assistance Publique des Hôpitaux de Marseille, France
5 CeRESS Team, Aix-Marseille University, France
One Year After the Opening of a Cleanroom: What Is the Level of Chemical Contamination and How Should It Be Interpreted? C. Leblond 1, D. Goulley 1,2, Corinne Pernot 1
1. Dijon University Hospital, France
2. Faculty of Health Sciences, Dijon, France
Assessment of surface contamination by cytotoxic anticancer drugs in hospital settings F. Jardon, C. Saci, B. Mauguen, F. Morey, J. Borsato
Centre Hospitalier de Bourg-en-Bresse, France
Reallocation of Chemotherapy Preparations: When Economics Meets Ecology O. Gautier, H. Aboudagga, M. Jardin, S. Renet
Pharmacy Department, Paris Saint-Joseph Hospital Group, France
Methotrexate residues on the outer surface of medicine vials: from contamination assessment to the testing of two decontamination procedures F. Chancelier 1, G. Bellagamba 2, H. Roussel 1, A. Villa 2,3, V. Servant 1, M. Canal-Raffin 4,5
1. Pharmaceutical Technology Department, Bordeaux University Hospital, France
2. Occupational and Environmental Pathology Department, Assistance Publique des Hôpitaux de Marseille, France
3. CeRESS Team, Aix-Marseille University, France
4. Pharmacology and toxicology Laboratory, Bordeaux University Hospital, France
5. Inserm U1219, EPICENE team, University of Bordeaux, France
Cyberattack or IT system failure: a survival kit for a sterile compounding production unit M. Fourgeaud, A. Blanchet, M. Sangnier, G. Herbin, MS. Pidoux
Groupe Hospitalier Saintes-St-Jean-d’Angély, Saintes, France
Risk mapping in quality control of Volatile Fatty Acid solutions : An FMEA study A. Brushko, L. Tilipet, N. Pons-Kerjean, V. Vanneaux
APHP, Hôpital Beaujon, Clichy, France
1. Pharmacy department, Centre Hospitalier de Valence, France
2. Occupational health department, Centre Hospitalier de Valence, France
Securing the Preparation Process for Sterile Injectable Anticancer Drugs in a Cytotoxic Safety Cabinet L. Fourcaud, S. Hermann, G. Hily, D. Sankhare, N. Jourdan, I. Madelaine, M. Brault
APHP, Hôpital Saint-Louis, Paris, France
Environmental monitoring of residual contamination of work surfaces by 14 antineoplastic drugs in 11 French chemotherapy reconstitution units between 2023 and 2025 M. Nehlil 1, C. Wadela 2, B. Atgé 3, C. Sciaux 3, A. Villa 4,5, M. Canal-Raffin 1,2
1 Pharmacology and toxicology Laboratory, Bordeaux University Hospital, France
2 Inserm U1219, EPICENE team, University of Bordeaux, France
3 AHI 33, Bordeaux, France
4 Occupational and Environmental Pathology Department, Assistance Publique des Hôpitaux de Marseille, France
5 CeRESS Team, Aix-Marseille University, France
One Year After the Opening of a Cleanroom: What Is the Level of Chemical Contamination and How Should It Be Interpreted? C. Leblond 1, D. Goulley 1,2, Corinne Pernot 1
1. Dijon University Hospital, France
2. Faculty of Health Sciences, Dijon, France
Assessment of surface contamination by cytotoxic anticancer drugs in hospital settings F. Jardon, C. Saci, B. Mauguen, F. Morey, J. Borsato
Centre Hospitalier de Bourg-en-Bresse, France
Reallocation of Chemotherapy Preparations: When Economics Meets Ecology O. Gautier, H. Aboudagga, M. Jardin, S. Renet
Pharmacy Department, Paris Saint-Joseph Hospital Group, France
Methotrexate residues on the outer surface of medicine vials: from contamination assessment to the testing of two decontamination procedures F. Chancelier 1, G. Bellagamba 2, H. Roussel 1, A. Villa 2,3, V. Servant 1, M. Canal-Raffin 4,5
1. Pharmaceutical Technology Department, Bordeaux University Hospital, France
2. Occupational and Environmental Pathology Department, Assistance Publique des Hôpitaux de Marseille, France
3. CeRESS Team, Aix-Marseille University, France
4. Pharmacology and toxicology Laboratory, Bordeaux University Hospital, France
5. Inserm U1219, EPICENE team, University of Bordeaux, France
Cyberattack or IT system failure: a survival kit for a sterile compounding production unit M. Fourgeaud, A. Blanchet, M. Sangnier, G. Herbin, MS. Pidoux
Groupe Hospitalier Saintes-St-Jean-d’Angély, Saintes, France
Risk mapping in quality control of Volatile Fatty Acid solutions : An FMEA study A. Brushko, L. Tilipet, N. Pons-Kerjean, V. Vanneaux
APHP, Hôpital Beaujon, Clichy, France
E-Posters
Maintaining aseptic conditions in the face of unexpected events: performance qualification of a modular controlled atmosphere area dedicated to ATMPs and clinical trials
L. Epry, Y. Ho
Hôpital Armand Trousseau – AP-HP Sorbonne Université, Paris, France
Feasibility study of an oral biotin suspension suitable for a ketogenic diet for pediatric use C Pevet 1, D. Marchand 1, M. Bouchfaa 1,2, P. Odou 1,2
1. Centre Hospitalier Universitaire de Lille, France
2. Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France
Hôpital Armand Trousseau – AP-HP Sorbonne Université, Paris, France
Feasibility study of an oral biotin suspension suitable for a ketogenic diet for pediatric use C Pevet 1, D. Marchand 1, M. Bouchfaa 1,2, P. Odou 1,2
1. Centre Hospitalier Universitaire de Lille, France
2. Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France
